Articles: health.
-
Journal of medical ethics · Sep 1986
Prenatal diagnosis and female abortion: a case study in medical law and ethics.
Alarm over the prospect that prenatal diagnostic techniques, which permit identification of fetal sex and facilitate abortion of healthy but unwanted female fetuses has led some to urge their outright prohibition. This article argues against that response. ⋯ Further, conditions in some societies may sometimes render excusable the inclination to abort certain healthy female fetuses. In places where abortion for fetal sex alone is recognised as unethical, however, medical licensing authorities already possess the power to discipline, for professional misconduct, physicians who prescribe or perform prenatal diagnosis purely to identify fetal sex, or those who disclose fetal sex when that is unrelated to the fetus's medical condition.
-
The United Nations Relief and Works Agency for Palestine refugees (UNRWA) has provided health, education, and welfare services since 1949. A team of physicians from Georgetown University visited UNRWA Health Centers and refugee camps in Jordan, Lebanon, the West Bank, and the Gaza Strip, as well as some affiliated hospitals. ⋯ Effective programs for health education, maternal and child health, and immunization have markedly improved the health of the refugees over the years of UNRWA's operation. The general health of the population is good, primarily as a result of wise emphasis on public health and preventive medicine measures.
-
Randomized Controlled Trial Clinical Trial
Field trial of oral cholera vaccines in Bangladesh.
The protective efficacy of oral B subunit killed whole-cell (BS-WC) and killed whole-cell (WC) cholera vaccines was assessed in 63 498 Bangladeshi children aged 2-15 years and women aged over 15 years. Each received three doses of BS-WC, WC, or placebo in a randomised, double-blinded fashion. Surveillance for cases seeking medical care up to six months after the third dose revealed 26 cases of confirmed cholera in the placebo group, 4 cases in the BS-WC group (protective efficacy 85%; p less than 0.0001), and 11 cases in the WC group (protective efficacy 58%; p less than 0.01). For each vaccine protective efficacy was consistent in different age-groups (2-10 years versus greater than 10 years) and for different severities of cholera.